Potential Winner Picked - Ian Frazer, page-17

I think it's you who are the naive one TZ. All big pharmas keep their eye in developments, and I have never said otherwise - what I did say is that it matters little who the scientific director is - only results count and they are far away.

You and others have been going on for over a year now about how brilliant AHZ is but the sp is a lousy 13.5c after all this time. Then you were saying the next 4C will make a difference, but you've changed that now to the following 4C.... you just keep shifting the goal posts.
The fact is the market has little faith in AHZ at this time and the big pharmas could care less about some obscure little Aussie medical device manufacturer. They are the facts of life for AHZ at this time and not the hype/tripe trotted out continuously by yourself and others.